XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders Equity [Abstract]  
Schedule of Outstanding Warrants to Purchase Common Stock Issued to Stockholders As of March 31, 2024, the Company had the following outstanding warrants to purchase Common Stock issued to stockholders:
Warrant  Issuance Date  Expiration
Date
  Exercise
Price
Per Share
   Number of
Shares of
Common Stock
Underlying
Warrants
 
Public Warrants  IPO (December 13, 2018)  October 28, 2024   11.50    3,500,000 
2021 Registered Direct Offering Warrants  SPA (July 28, 2021)  January 28, 2027   5.00    2,812,501 
Pre-Funded Warrants  February 27, 2023  -   0.001    1,869,755 
Pre-Funded Warrants  May 4, 2023  -   0.001    7,962,694 
Merger Warrants  March 15, 2024  January 28, 2027   5.00    2,166,497 
Private Placement Warrants  March 15, 2024  Two years after the stockholder approval   0.2311    108,208,500 
Agents Warrants  March 15, 2024  Two years after the stockholder approval   0.2311    9,523,809 
               136,043,756 
Schedule of Fair Value Of The Agents Warrants Using The Black-Scholes Model
   Three Months Ended
March 31,
 
   2024   2023 
Underlying value of Common Stock ($)   0.23    
      -
 
Exercise price ($)   0.23    
-
 
Expected volatility (%)   100.6    
-
 
Expected terms (years)   2.32    
-
 
Risk-free interest rate (%)   4.4    
-
 

 

Schedule of Options Granted to Purchase A summary of options granted to purchase the Company’s Common Stock under the Company’s share option plans is as follows:
   For the Three Months Ended
March 31, 2024
 
   Number of
Options
   Weighted
Average
Exercise Price
   Aggregate
Intrinsic
Value
 
Outstanding at the beginning of period   5,280,711   $0.54   $72 
Granted   
-
   $
-
      
Forfeited   (87,363)  $0.37      
Expired   
-
    
-
      
Exercised   
-
   $
-
      
Outstanding at the end of period   5,193,348    0.54   $587 
Exercisable at the end of period   3,249,620    0.57      
Weighted average remaining contractual life of outstanding options – years as of March 31, 2024   6.42           
Schedule of Outstanding Compensation Related Warrants to Purchase Common Stock As of March 31, 2024, the Company had the following outstanding compensation related warrants to purchase Common Stock:
Warrant  Issuance
Date
  Expiration
Date
  Exercise
Price
Per Share
   Number of
Shares of
Common Stock
Underlying
Warrants
 
Private Warrants issued to scientific founders  November 27, 2017 
 
   
-
    2,974 
Landlord Warrants*  March 15, 2024  January 28, 2027   5.00    250,000 
               252,974 
(*) See note 6.

   

Schedule of Stock-Based Payment Expenses The following table sets forth the total stock-based payment expenses resulting from options granted, included in the statements of operations:
   Three Months Ended
March 31,
 
   2024   2023 
Research and development expenses, net   65    87 
General and administrative   112    88 
    177    175